DH assessing use of polypill for cardiovascular disease
By Nigel Praities
Minsters are assessing the impact of introducing a polypill containing statins and other medications into the UK.
The Department of Health responded to recent calls for more Government incentives for polypill research by announcing it was re-looking at the issue.
Health minister Ann Keen said: ‘The Department has met the original Polypill authors on a number of occasions.
‘The initial conclusions were that this type of approach would be more suitable in developing countries rather than in more sophisticated healthcare systems such as ours where tailored therapy is more the norm.
‘The Department is currently exploring how to reassess this issue in the light of fresh interest in the topic,' she said.
Recent data from a US conference showed a five-drug polypill could reduce the risk of heart disease by more than a quarter.